Cross-institution positioning
Aug 12, 2026Strong institutional reduction. 1 exited across 1 comparable institution.
Source: Schedule 13 researchSee how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 1 exited across 1 comparable institution.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 1 sale by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/53 non-amendment material events in the last 90 days; Latest classified evidence: Other event. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +11.7% YoY; Net income +13.3% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 11% through its reported 52-week range; -22.4% over one year.
Source: Stored historical price seriesFiled Aug 12, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Cavalcanti Guilherme Perboyre | SOpen-market or private sale | Class A Common Shares | 183.5K | $13.85 | Direct | Aug 25, 2026 |
| Jun 9, 2026 | Cavalcanti Guilherme Perboyre | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 112.1K | — | Direct | Jun 10, 2026 |
| May 21, 2026 | O'Callaghan Jeremiah Alphonsus | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 27.2K | — | Direct | May 22, 2026 |
| May 21, 2026 | O'Callaghan Jeremiah Alphonsus | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 49.6K | — | Direct | May 22, 2026 |
| May 21, 2026 | Cavalcanti Guilherme Perboyre | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 185.8K | — | Direct | May 22, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 15, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Aug 19, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Aug 11, 2026 | 8-K | 2.02, 5.02, 7.01, 9.01 | Results of operations / financial condition; Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Dec 11, 2025 | 424B3 | — | Prospectus filing | Capital-related | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $86.2B | +11.7% |
| Ended Dec 31, 2024 | $77.2B | +5.8% |
| Ended Dec 31, 2023 | $72.9B | — |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors CIK0001422848 | Jun 30, 2026 observed Aug 12, 2026 filed · 43d Schedule 13G amendment | Exit below reporting threshold | 34.4M -779.8M | 4.40% -7.60 pts | $11.85 | $13.12 | $12.98 |
| Capital Research Global Investors CIK0001422848 | Sep 30, 2025 observed Nov 13, 2025 filed · 44d Initial Schedule 13G | Initial Schedule 13G | 814.2M | 12.00% | $14.93 | $13.14 | $12.98 |
| Capital Research Global Investors CIK0001422848 | Jun 30, 2025 quarter end Aug 13, 2025 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 144.5K | $12.98 |
Compare JBS with other securities showing similar institutional activity or recent accumulation across several tracked institutions.